356 related articles for article (PubMed ID: 16508838)
1. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
2. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions.
Böhm I; Speck U; Schild H
Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253
[TBL] [Abstract][Full Text] [Related]
3. Pilot study on basophil activation induced by contrast medium.
Böhm I; Speck U; Schild HH
Fundam Clin Pharmacol; 2011 Apr; 25(2):267-76. PubMed ID: 20412314
[TBL] [Abstract][Full Text] [Related]
4. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
Hoffmeister HM; Fuhrer G; Platten HP; Heller W
Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profiles after nonionic dimeric contrast medium injection.
Böhm I; Speck U; Schild H
Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
[TBL] [Abstract][Full Text] [Related]
6. Urography with monomeric and dimeric nonionic contrast media: comparative, randomized, double-blind study of iotrolan 280 and iopromide 300.
Taenzer V; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():116-8. PubMed ID: 2568778
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
[TBL] [Abstract][Full Text] [Related]
8. [Determination of hematocrit and iodine concentrations following intravenous bolus administration of ionic and nonionic monomeric and dimeric contrast media--an animal experimental study].
Claussen CD; Duda SH; Weinmann HJ
Rofo; 1988 Nov; 149(5):529-33. PubMed ID: 2848287
[TBL] [Abstract][Full Text] [Related]
9. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
Nauert C; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
[TBL] [Abstract][Full Text] [Related]
10. Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan.
Ueda J; Nygren A; Hansell P; Erikson U
Acta Radiol; 1992 Nov; 33(6):596-9. PubMed ID: 1449888
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
Hagen B; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
[TBL] [Abstract][Full Text] [Related]
12. [Oral administration of intravenous contrast media: a tasty alternative to conventional oral contrast media in computed tomography].
Diederichs G; Franiel T; Asbach P; Romano V; Hamm B; Rogalla P
Rofo; 2007 Oct; 179(10):1061-7. PubMed ID: 17786895
[TBL] [Abstract][Full Text] [Related]
13. Adverse skin reactions to iodinated x-ray contrast agents in healthy rats.
Lenhard DC; May E; Morgenroth C; Jost G; Haider W; Pietsch H
Invest Radiol; 2014 Dec; 49(12):779-87. PubMed ID: 24988006
[TBL] [Abstract][Full Text] [Related]
14. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
Roncato M; Vial MC; Maillet F; Peltier A
Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
[TBL] [Abstract][Full Text] [Related]
15. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
16. Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media.
Aronen HJ; Kivisaari L; Torstila I; Paavonen T; Meri S; Karonen SL; Standertskjöld-Nordenstam CG
Acta Radiol; 1992 Jul; 33(4):374-8. PubMed ID: 1378750
[TBL] [Abstract][Full Text] [Related]
17. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical properties and general pharmacology of the nonionic dimer iotrolan.
Mützel W; Press WR; Weinmann HJ
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():28-32. PubMed ID: 2568804
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
Janssen CW; Tønder O; Matre R
Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
